Literature DB >> 15199437

Case-finding for familial hypercholesterolemia in the Asia-Pacific region.

Ian Hamilton-Craig1.   

Abstract

It is estimated that in the Asia-Pacific region, more than 5.2 million persons are suffering from familial hypercholesterolemia (FH). This means that more than half of the estimated world total of 10 million FH patients are living in this part of the world, of which the vast majority is not aware of their dangerous condition, let alone being adequately treated. Obviously, an intensive case-finding program to identify patients and subsequent clinical management are required to prevent premature cardiovascular disease and death caused by the consequences of inherited hypercholesterolemia. This article describes the current situation concerning FH and the initiatives and actions undertaken in Australia to contribute to actively identifying patients with FH in that country.

Entities:  

Mesh:

Year:  2004        PMID: 15199437     DOI: 10.1055/s-2004-822990

Source DB:  PubMed          Journal:  Semin Vasc Med        ISSN: 1528-9648


  4 in total

1.  Knowledge and Awareness of Familial Hypercholesterolaemia among Registered Medical Practitioners in Tamil Nadu: Are They Suboptimal?

Authors:  Nandhini Rangarajan; Shanthi Balasubramanian; Jing Pang; Gerald F Watts
Journal:  J Clin Diagn Res       Date:  2016-05-01

Review 2.  Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia.

Authors:  Ian Hamilton-Craig; Karam Kostner; David Colquhoun; Stan Woodhouse
Journal:  Vasc Health Risk Manag       Date:  2010-11-10

3.  Cascade Screening for Familial Hypercholesterolemia (FH).

Authors:  Renée M Ned; Eric J G Sijbrands
Journal:  PLoS Curr       Date:  2011-05-23

4.  An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the "Ten Countries Study".

Authors:  Jing Pang; Miao Hu; Jie Lin; Takashi Miida; Hapizah M Nawawi; Jeong Euy Park; Xue Wu; Anis S Ramli; Ngoc Thanh Kim; See Kwok; Lourdes E Gonzalez-Santos; Ta-Chen Su; Thanh Huong Truong; Handrean Soran; Shizuya Yamashita; Brian Tomlinson; Gerald F Watts
Journal:  BMJ Open       Date:  2017-10-25       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.